Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Resmed Inc
OTC:RSMDF
Resmed Inc
OTC:RSMDF
Price:
22.61
USD
Market Closed
Market Cap:
$33.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Resmed Inc
OTC:RSMDF
|
US |
|
D
|
Denison Mines Corp
F:IUQ
|
CA |
|
Coca-Cola HBC AG
LSE:CCH
|
CH |
|
S
|
Spur Corporation Ltd
JSE:SUR
|
ZA |
|
Spire Global Inc
F:EL9
|
US |
|
Activeops PLC
F:95D
|
UK |
|
Capitol Federal Financial Inc
NASDAQ:CFFN
|
US |
|
K
|
Kimberly-Clark Corp
DUS:KMY
|
US |
|
SOL SpA
MIL:SOL
|
IT |
|
A
|
African Rainbow Minerals Ltd
JSE:ARI
|
ZA |
Wall St Price Targets
RSMDF Price Forecast
Based on 19 analysts
Based on 19 analysts
+5% Upside
from
$22.61
today
Resmed Inc (RSMDF)’s 12-month stock price forecast through October 2027 has a consensus target of $23.79, implying 5% upside. The forecast is based on price targets from 19 Wall Street analysts.
RSMDF Analyst Rating
No ratings yet
No ratings yet
Resmed Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RSMDF's stock price target?
Price Target
23.79
USD
23.79
USD
According to Wall Street analysts, the average 1-year price target for RSMDF is 23.79 USD with a low forecast of 17.18 USD and a high forecast of 32.65 USD.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
6%
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
7%
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
8%
8%
Over the last 14 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 8%.
What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
9%
9%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
9%
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 9%.